Typhoon Yinxing battered the northern Philippines with floods and landslides before ... Health Canada has approved Moderna's ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

Effective dengue prevention requires a combination of vector control and vaccination efforts, a group of physicians said ...

Investing.com - Moderna (NASDAQ:MRNA) has reported a surprise net income in the third quarter and announced changes at its ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

Moderna’s move into personalised cancer therapy continues to proceed at a rapid pace, with Merck & Co-partnered melanoma vaccine mRNA-4157 heading for a pivotal phase 3 programme after a phase ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Merck and Moderna initiate Phase 3 trial of mRNA-4157 (V940) with Keytruda as adjuvant for NSCLC patients, marking progress in individualized cancer therapies. Vandana Singh Benzinga Bulls And ...

The mRNA vaccine from Moderna has entered its final stages of testing, the Health Secretary has announced, with results so far showing it creates a 'strong immune response'.

How do you feel about automated vehicles? What effects do you think they will have on your generation? Read this article and post your comments and questions for Matt Richtel by Nov. 14. By The ...

A jury has awarded more than $12 million to a woman who lost her job at a Michigan insurance company after declining to get a COVID-19 vaccination A ship suspected of carrying a large amount of ...